v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 394,919 $ 224,134 $ 738,889 $ 429,883
General and administrative 110,213 40,580 211,465 75,591
Total operating expenses 505,132 264,714 950,354 505,474
Loss from operations (505,132) (264,714) (950,354) (505,474)
Non-operating income (expense), net:        
Interest income 35,579 22,404 55,087 47,319
Interest expense (23,781) (867) (35,978) (867)
Change in fair value of warrant liability (151,031) (4,578) (166,819) (2,139)
Other expense, net (6) (32) (123) (42)
Total non-operating income (expense), net (139,239) 16,927 (147,833) 44,271
Loss before income taxes (644,371) (247,787) (1,098,187) (461,203)
Net loss $ (644,371) $ (247,787) $ (1,098,187) $ (461,203)
Net loss per share attributable to common stockholders, basic $ (3.06) $ (1.31) $ (5.37) $ (2.45)
Net loss per share attributable to common stockholders, diluted $ (3.06) $ (1.31) $ (5.37) $ (2.45)
Weighted-average common shares used to compute net loss per share, basic 210,893,604 188,583,288 204,531,173 188,365,805
Weighted-average common shares used to compute net loss per share, diluted 210,893,604 188,583,288 204,531,173 188,365,805
Comprehensive loss:        
Net Income (Loss) $ (644,371) $ (247,787) $ (1,098,187) $ (461,203)
Other comprehensive loss:        
Foreign currency translation adjustments (93) 0 (101) 0
Unrealized loss on investments, net (5,235) (405) (9,086) (19)
Comprehensive loss $ (649,699) $ (248,192) $ (1,107,374) $ (461,222)